LIVZON PHARMA (01513) has accumulated repurchased 9.426 million shares of A shares.
Lizhu Pharmaceutical (01513) announced that as of February 28, 2025, the company has completed the centralized auction trading...
LIVZON PHARMA (01513) announced that as of February 28, 2025, the company repurchased a total of 9.426 million A shares through centralized bidding trading, accounting for 1.03% of the total share capital. The highest purchase price was RMB 38.37 per share, the lowest price was RMB 35.18 per share, and the total amount of funds used was RMB 342 million (excluding transaction costs). The repurchase mentioned above complies with the company's established share repurchase program.
Related Articles

US Stock Market Move | Storage concept stocks collectively rose, SanDisk (SNDK.US) rose nearly 13%

US Stock Market Move | Q3 earnings per share significantly increased, Qudian, Inc. Sponsored ADR Class A (QD.US) rose over 6% in early trading.
A new era of the AI super cycle is opening. HSBC predicts that OpenAI may require up to $207 billion in new financing by 2030.
US Stock Market Move | Storage concept stocks collectively rose, SanDisk (SNDK.US) rose nearly 13%

US Stock Market Move | Q3 earnings per share significantly increased, Qudian, Inc. Sponsored ADR Class A (QD.US) rose over 6% in early trading.

A new era of the AI super cycle is opening. HSBC predicts that OpenAI may require up to $207 billion in new financing by 2030.





